Enorama Pharma AB (publ) (STO:ERMA)
Sweden · Delayed Price · Currency is SEK 0.4900
-0.0200 (-3.92%)
Mar 25, 2026, 4:45 PM CET
Enorama Pharma AB Market Cap
Enorama Pharma AB has a market cap or net worth of 38.04 million as of March 25, 2026. Its market cap has decreased by -70.33% in one year.
Market Cap
38.04M
Enterprise Value
35.00M
Revenue
2.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
Market Cap Chart
Since June 10, 2016, Enorama Pharma AB's market cap has increased from 35.83M to 38.04M, an increase of 6.18%. That is a compound annual growth rate of 0.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 38.04M | -73.30% |
| Dec 30, 2025 | 142.46M | -29.89% |
| Dec 30, 2024 | 203.19M | 77.51% |
| Dec 29, 2023 | 114.47M | 308.04% |
| Dec 30, 2022 | 28.05M | -83.60% |
| Dec 30, 2021 | 171.01M | -12.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.55B |
| Dicot Pharma AB | 844.93M |
| Cinclus Pharma Holding AB | 833.03M |
| Orexo AB | 788.60M |
| Nanexa AB | 625.42M |
| Enzymatica AB | 553.44M |
| Moberg Pharma AB | 491.16M |
| Klaria Pharma Holding AB (publ.) | 187.93M |